Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00846573 · ClinicalTrials.gov registry record · NA

Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders

A NA study, sponsored by University of Massachusetts, Worcester.

Terminated
Registry status
NA
Development phase
14
Enrollment target

NCT00846573: Clinical Trial NA study, sponsored by University of Massachusetts, Worcester.

NCT00846573 is a NA study that was terminated before completion, run by University of Massachusetts, Worcester. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00846573, a NA study, was terminated before completion, sponsored by University of Massachusetts, Worcester.

TERMINATED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

The purpose of this study is to test the efficacy of Hyperpolarized Helium-3 gas in MR imaging in COPD, asthmatics, CF and healthy volunteers.

Primary Outcome

We have applied hyperpolarized 3He MR imaging to a range of subject with various disorders. We have developed our scanning techniques so as to acquire optimized images for each disorder.

Interventions

  • DRUG Hyperpolarized Helium-3

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2008-11
Est. Completion 2011-04
Phase NA

Why NCT00846573 stopped before completion

NCT00846573 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Hyperpolarized Helium-3 is the first listed.

NCT00846573 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00846573 about?

NCT00846573 is a clinical study titled "Hyperpolarized Noble Gas MR Imaging for Pulmonary Disorders". The purpose of this study is to test the efficacy of Hyperpolarized Helium-3 gas in MR imaging in COPD, asthmatics, CF and healthy volunteers.

What is the current status of trial NCT00846573?

This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2008-11. Estimated completion is 2011-04.

What interventions are being tested in trial NCT00846573?

The interventions under investigation include: Hyperpolarized Helium-3 (DRUG).

Who is sponsoring clinical trial NCT00846573?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00846573's enrollment target sits among peer trials

14 1909th of 2000 higher than 90 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00846573, the US trial registry maintained by the National Library of Medicine. NCT00846573 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.